Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-02-02

Clinical Trial Update: Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline [Phase 4]

View source ↗

Summary

Phase 4 trial comparing pregabalin to sertraline for anxiety in epilepsy patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)
  • Sertraline (Sertraline)

Snippet

Sponsor: Rush University Medical Center | Conditions: Epilepsy, Anxiety | Phase 4 | Status: WITHDRAWN